Eleva Biologics and One04 split to advance partnerships and Factor H therapy
AI Summary- Eleva Biologics and One04 Therapeutics became stand-alone companies under eleva GmbH.
- CPV-104 is the only Factor H therapeutic candidate currently in the clinic.
- Phase 1 testing of CPV-104 reached a successful progression point before the separation.